Table 4.
Effect of choline ± methionine deficiency on hepatic de novo lipogenesis and newly synthesized hepatic fatty acid export
| CS | CDD | MCDD | |
|---|---|---|---|
| Liver | |||
| Acetyl CoA enrichment, % | 7.6 ± 0.6 | 8.9 ± 0.5 | 7.2 ± 0.3 |
| Liver TG pool, μmol/liver | 25.0 ± 2.3 | 38.2 ± 4.0 | 48.5 ± 5.0** |
| M + 2 enrichment | 0.104 ± 0.009 | 0.121 ± 0.008 | 0.132 ± 0.007 |
| M + 4 enrichment | 0.029 ± 0.003 | 0.041 ± 0.003* | 0.036 ± 0.003 |
| Fractional synthesis rate, %/day | 5.6 ± 0.7 | 5.9 ± 0.4 | 6.8 ± 0.3 |
| Absolute synthesis rate, μmol/day | 1.4 ± 0.3 | 2.3 ± 0.4 | 3.4 ± 0.4** |
| Plasma TG | |||
| Acetyl-CoA enrichment, % | 7.6 ± 0.5 | 8.9 ± 0.4 | 7.4 ± 0.4 |
| TG pool, μmol | 1.7 ± 0.3 | 1.5 ± 0.2 | 1.0 ± 0.1* |
| Fractional synthesis rate, %/day | 6.5 ± 0.5 | 6.2 ± 0.4 | 6.6 ± 0.7 |
| Absolute synthesis rate, μmol/day | 0.33 ± 0.05 | 0.27 ± 0.04 | 0.19 ± 0.03* |
Results are means ± SE, analyzed by 1-way ANOVA with Tukey's post hoc tests where appropriate. Absolute synthesis rates were calculated from mass isotopomer distribution analysis of TG-derived palmitate following dietary [13C2]acetate labeling. The absolute synthesis rate of plasma TGs represents the hepatic export of newly synthesized fatty acids.
P < 0.05,
P < 0.01 vs. CS; n = 8/group, except for plasma TG data, where n = 5–7/group.